IP Radar -Most Impactful Patents Granted Globally – Week Ending September 15-22, 2025
- Ineurous IP
- Sep 23, 2025
- 3 min read
Introduction
Patents remain the cornerstone of innovation by protecting transformative ideas and enabling new technologies to reach the market. This weekly roundup spotlights the most impactful patents granted around the world in fields critical to the future of industry, healthcare, sustainability, and computing. These highlights help innovators, startups, and IP professionals track trends and identify emerging opportunities.

Featured Patents of the Week
1. Lab-on-a-Patch Wearable for Real-Time Biomarker Monitoring
Patent Number: Not publicly disclosed (Australia/US/EU filings)
Granting Authority: Multiple – Recent grant in Australia
Assignee: Nutromics Pty Ltd
Field: MedTech, Wearables, Diagnostics
Summary: An adhesive patch using DNA-based biosensors tracks hundreds of patient biomarkers beyond glucose, targeting conditions like sepsis and supporting critical care drug dosing. Its modular biosensing can drive major advances in precision medicine and remote patient monitoring, with future FDA approval aimed for 2028.
2. Silk Nano-Gel Injector for Drug Delivery
Patent Number: Not disclosed (India)
Granting Authority: Controller General of Patents, Designs, and Trade Marks (India)
Assignee: Not disclosed (India)
Field: Healthcare, Biomaterials, Oncology
Summary: A device leveraging silk fibroin nanogels for targeted, localized drug release, reducing side effects and supporting applications in cancer therapy, wound healing, and regenerative medicine. Its eco-friendly, biodegradable design positions it strongly in the green medtech movement.
3. Hemopurifier Device for Filtering Viral Proteins
Patent Numbers: Two new US patents in 2025 (Exact numbers not specified)
Granting Authority: United States Patent and Trademark Office (USPTO)
Assignee: Aethlon Medical Inc.
Field: Medical Devices, Infectious Disease, Therapeutics
Summary: Protects a blood filtration device that removes viral proteins to treat Long COVID and COVID-associated coagulation issues, addressing persistent global health crises and laying groundwork for future anti-viral therapies.
4. Injectable Microgel Scaffolds for Implant and Regenerative Therapies
Patent Number: US 20250177611 (Patent Application)
Granting Authority: USPTO
Assignee: Not disclosed
Field: Regenerative Medicine, Implants, Materials Science
Summary: Describes injectable fluidic scaffolds that crosslink inside the body to support tissue integration in prosthetics, implants, and healing. This could revolutionize the interface between devices and living tissue.
5. Injectable Thermoresponsive Hydrogels for Controlled Drug Release
Patent Number: US 12,377,149
Granting Authority: USPTO
Assignee: Not disclosed
Field: Pharmaceutics, Biomaterials, Drug Delivery
Summary: Covers hydrogels that undergo sol-gel transitions at body temperature, allowing for precise, sustained release of therapeutics, potent in chronic disease management and advanced injectable medicines.
6. Sustainable Breast Cancer Screening Tool
Patent Number: Not specified (India; September 2025 grant)
Granting Authority: Controller General of Patents (India)
Assignee: Indian research team (names not disclosed)
Field: Medical Devices, Diagnostics, Sustainability
Summary: Incorporates eco-conscious materials and reduced radiation exposure for breast cancer screening, aligning with global trends for safer, greener healthcare innovation.
7. Quattrii Dry-Powder Inhaler for Direct Lung Delivery
Patent Number: Not specified (UK/Europe)
Granting Authority: European Patent Office (recent grant in 2025)
Assignee: Cambridge Healthcare Innovations
Field: Pharmaceuticals, Inhaler Devices
Summary: Innovation dramatically increases lung deposition of medication (>70% vs <10%) to improve respiratory therapy efficiency; Phase 1 trials expected to start this month.
Trends and Insights
MedTech and Biotech Dominate: Most impactful patents this week are in medical technologies, especially wearables, biomaterials, and advanced diagnostic devices. The pace of innovation in personalized treatment and remote patient health management continues to accelerate.
Eco-Conscious Innovation: Green devices and materials—such as biodegradable nanogels and sustainable diagnostic tools—show strong patent activity, reflecting industry and regulatory pressure for low-impact healthcare solutions.
AI and Digital Health: While AI-driven patents remain high in volume (notably in healthcare and diagnostics), this week’s granted inventions lean towards foundational materials and biosensing, often as enabling platforms for AI-powered analytics in the near future.
Outlook
The latest patents signal rapid evolution of biomaterials, drug delivery platforms, and diagnostic tools with real-world commercial and clinical impact across continents. Patent grants in green healthcare and digital diagnostics position their owners for leadership in emerging markets, with future value amplified by regulatory approvals and adoption in clinical settings. Continued investment in IP protections and global innovation collaboration will shape competitive advantage for startups, companies, and institutions in the coming year.
Stay Connected with Us
At Ineurous IP, we regularly share updates and guidance regarding IPR.
👉 Follow us for more updates:
🌐 Website: www.ineurousip.com
📱 WhatsApp Channel: https://whatsapp.com/channel/0029VbB4arfJENxygb3NbR3L
☎️ Contact Us: +91-7065569010
💡 Join our WhatsApp Channel today to get daily dose of IPR.


